Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Burdened Biopure keeps afloat with cash injection

This article was originally published in Clinica

Executive Summary

The last week has seen Biopure, the troubled blood substitute firm, receive a couple of much-needed boosters. The Cambridge, Massachusetts-based company closed a successful round of financing, netting $10.5m in proceeds after placing 40 million shares with institutional and individual investors. Cash-strapped Biopure had announced earlier in December that it expected its funds to dry up by January 2005 and needed to raise an additional $19m to keep it operational through the coming fiscal year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel